The NM_003494.4: c.5979dup p.(Glu1994ArgfsTer3) variant in DYSF, which is also known as NM_001130987.2: c.6096dup p.(Glu2033ArgfsTer3), is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 53/55, leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1). This variant has been reported in at least seven unrelated individuals with features consistent with LGMD (PMID: 26404900, 14678801, 36983702, 18853459), including in a homozygous state (0.25 pts, PMID: 18853459) and in unknown phase with a variant classified as at least likely pathogenic (NM_003494.4: c.5057+5G>A, 0.25 pts, PMID: 36983702) (PM3_Supporting). At least one patient with this variant displayed progressive limb girdle muscle weakness and severely reduced or absent dysferlin protein expression in skeletal muscle or blood monocytes, which is highly specific for DYSF-associated LGMD (PP4_Strong, PMID: 14678801, 36983702, 18853459). The filtering allele frequency of this variant is 0.0003511 (the upper threshold of the 95% CI of 9/44724 Admixed American exome chromosomes) in gnomAD v4.1.0, which is greater than the ClinGen LGMD VCEP threshold (≤0.0001) (PM2_Supporting not met). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb-girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 02/25/2025): PVS1, PM3_Supporting, PP4_Strong.